←
Neuroendocrine Cancer Foundation3,996 posts
Neuroendocrine Cancer Foundation avatar

Neuroendocrine Cancer Foundation

@NCFCancer

The Neuroendocrine Cancer Foundation (previously known as LACNETS) provides a community of support & education for those with neuroendocrine cancer.

◷ Joined February 2010▧ 1,987 Photos and videos
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Nov 15

📢Amplifying Patient Voices in Neuroendocrine Carcinoma Research We're proud to have collaborated on the VOICE Study, presented at #esmo26 and #NANETS2026, highlighting the experiences, challenges, and unmet needs of people affected by extrapulmonary neuroendocrine carcinoma (epNEC), meaning neuroendocrine carcinoma that originates outside the lungs. The study surveyed 226 patients across the U.S., revealing important insights: 🔷 54% waited more than a month after symptoms began before seeking medical attention. 🔷 Patients reported significant impacts on their physical health, emotional well-being, and daily activities. 🔷 94% were willing to undergo biomarker testing to help guide treatment decisions. 🔷 Key unmet needs include greater access to specialists and novel therapies, more treatment options and educational resources, and greater involvement in treatment decisions. NCF's Director of Programs & Outreach, Lisa Yen, was honored to help present this important research at #NANETS2026. We're grateful to @AmanChauhanMD, Dr. Jason Starr, @Boehringer, and our fellow patient advocacy organizations for their collaboration. Most importantly, thank you to every patient, care partner, and HCP who shared their experiences. Your voices are helping shape the future of NEC care. Together, we're working toward greater awareness, better access to care, and improved outcomes for the NEC community. Read the full blog post here: ncf.net/post/amplifying-pati… @HealingNET1 @NANETS1 @CureNETs @netcanceraware #NeuroendocrineCancer #Neuroendocrinecarcinoma #epnec #voicestudy #nanets2026 #ESMO2026 #PatientAdvocacy #ncfcancer

Post attachmentPost attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Nov 11

This Veterans Day, We Celebrate a Remarkable Story of Courage! We are thrilled to share that the award-winning documentary The Commitment to Courage: The Ashley Christman Story is now streaming on PBS through KPBS! Today, we proudly honor Ashley Christman, a decorated U.S. Marine Corps officer whose courage extends far beyond her military service. After years of unexplained symptoms and advocating for answers, Ashley was diagnosed with stage IV neuroendocrine cancer in 2021. Her journey through military service, family life, and cancer is a powerful testament to resilience, determination, and self-advocacy. Produced by the Carcinoid Cancer Foundation, whose legacy continues through the Neuroendocrine Cancer Foundation (NCF), the documentary was directed by our friend and collaborator Rain Bennett, host of NCF's Luncheon With The Experts educational series. 🎥 The film won Best Documentary Short at the 2026 GI Film Festival San Diego, and we're excited that Ashley's inspiring story can now reach an even wider audience through PBS! On this Veterans Day, we thank Ashley and all who have served our nation. Their courage and sacrifice inspire us every day. 📺 Watch and share the documentary: video.kpbs.org/video/the-com… #VeteransDay #CommitmentToCourage #NeuroendocrineCancer #PatientAdvocacy #PBS #GIFFSD

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Nov 10

🦓November 10 | World NET Cancer Day Think Zebras Learn. Share. Make a Difference. Today, the Neuroendocrine Cancer Foundation (NCF) joins the global community in raising awareness, honoring patients and caregivers, and supporting everyone affected by neuroendocrine cancer. Neuroendocrine cancer is complex, often misunderstood, and can be difficult to diagnose. While neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs) are distinct diagnoses, every patient deserves access to education, specialized care, and compassionate support. 📢 Explore our awareness page: Find facts, educational resources, and ways to help spread awareness. ncf.net/awareness 📚New from NCF  — Dedicated NEC Resources: Information to help patients and caregivers understand an NEC diagnosis, explore treatment options, and find support. ncf.net/nec On World NET Cancer Day, we honor those living with neuroendocrine cancer, remember those we've lost, and recognize the families, caregivers, healthcare professionals, and advocates who make a difference every day. Awareness starts with a conversation. Help us spread the word. #WorldNETCancerDay #NETCancerDay #ThinkZebra #NeuroendocrineCancer #NeuroendocrineTumors #NEC #NETAwareness #NCFCancer #LetsTalkAboutNETs

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Nov 7

🦓 Together in Awareness. Stronger Through Connection. Join the Neuroendocrine Cancer Foundation (NCF) for the 2026 NET Cancer Day Symposium in Las Vegas! In honor of World NET Cancer Day, we're bringing patients, caregivers, families, and leading medical experts together for a meaningful day of education, empowerment, and community. 🗓️ Sunday, November 8, 2026 ⏲️ 8:00 AM – 3:00 PM 📍 JW Marriott Las Vegas Resort & Spa, Las Vegas, NV What to Expect: - Expert discussions on neuroendocrine cancer diagnosis, treatments, and emerging therapies - Interactive Q&A sessions with leading specialists - Opportunities to connect with patients, caregivers, and healthcare professionals - Complimentary breakfast, lunch, and a dessert reception Attendance is FREE for patients and family members! Whether you're newly diagnosed, navigating treatment, or supporting someone you love, this event offers valuable knowledge, meaningful connections, and a community that understands. Register today: ncf.net/events/ncd2026 #NETCancerDay #NeuroendocrineCancer #NETcancerawareness #worldnetcancerday #ncfcancer #cancercommunity #lasvegas

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Oct 29

📌 Join us for an upcoming virtual webinar: “Liver NETs: Understanding Liver-Directed Therapies and PRRT” 🗓️ Thursday, October 29, 2026 ⏲️ 4:00–5:30 PM Pacific 💻 Virtual Event Join Gabriel Fine, M.D., a diagnostic radiologist and nuclear medicine specialist at City of Hope Cancer Center, for an overview of liver-directed therapies and peptide receptor radionuclide therapy (PRRT). The discussion will explore how treatment decisions are made, when different approaches may be considered, and how these therapies can fit into an overall NET treatment plan. There will also be an opportunity to submit general questions for Dr. Fine to address during the live Q&A. ➡️ Learn more and register: ncf.net/events/oct2026 #NeuroendocrineCancer #NETcancer #neuroendocrinetumors #livernets #prrt #CancerEducation #PatientEducation #CancerSupport #netcommunity

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 29

Join the Neuroendocrine Cancer Foundation for “Practical Tips in Managing Your Neuroendocrine Cancer Care” today from 10:00–11:30 AM Pacific. Taymeyah Al-Toubah and Tiffany Romershausen, MPH, MSN, AGPCNP-C, of Moffitt Cancer Center share important insights to help you spearhead your medical team and confidently navigate your healthcare. Gain practical logistics for managing the ongoing cycle of scans, lab work, and "ologist" appointments. Discover well-informed, real-world suggestions on finding and building strong partnerships with your providers and specialists. We hope this discussion empowers you to effectively and efficiently coordinate your care. Topics include: ✨ Coordinating NET care ✨ Working with NET specialists ✨ Preparing for oncology appointments ✨ Patient advocacy and second opinions ✨ Scans and symptom management ✨ Communicating effectively with your medical team 💻 This is a virtual event. Watch it here: ncf.net/events/sep2026 #NeuroendocrineCancer #NETcancer #NeuroendocrineTumor #cancersupport #PatientAdvocacy #cancercaregiver #netcommunity #ncfcancer

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 23

📣 New FDA Approval for the Neuroendocrine Cancer Community The U.S. Food and Drug Administration (FDA) has approved BRAVNETSA™ (lutetium Lu-177 dotatate) injection for the treatment of adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (SSTR-positive GEP-NETs), including foregut, midgut, and hindgut NETs. BRAVNETSA offers another treatment option for patients and families navigating neuroendocrine tumors. Please note: BRAVNETSA is not currently commercially available. Additional information about availability is expected in the future. Learn more and review the full prescribing and safety information: lantheus.com/bravnetsa-presc… Availability updates: bravnetsahcp.com/ #neuroendocrinetumors #NETcancer #gepnets #nuclearmedicine #PatientAdvocacy #ncfcancer @LantheusNews

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 17

Join us TODAY for Luncheon With The Experts featuring Aman Chauhan, MD, MBBS, medical oncologist and Associate Professor of Medicine at UCSF. @AmanChauhanMD specializes in neuroendocrine cancers, with expertise spanning clinical trials, radiopharmaceutical therapy, theranostics, treatment sequencing, symptom management, and guideline development. 📅 Thursday, September 17, 2026 ⏰ 12 PM Eastern / 9 AM Pacific 📍 Live on Facebook and YouTube ✅ No registration required Bring your questions! Dr. Chauhan will answer audience questions live—just leave yours in the Facebook comments or YouTube chat. The session will also be recorded and available afterward. Learn more and watch: ncf.net/lwte/sep2026 #NeuroendocrineCancer #NETcancer #neuroendocrinetumors #CancerEducation #luncheonwiththeexperts #ncfcancer

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 15

The FDA has approved BEXLUTRY™ (lutetium Lu 177 dotatate injection) from Curium for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors, also known as SSTR-positive GEP-NETs. BEXLUTRY is a radioligand therapy designed to bind to somatostatin receptors commonly found on GEP-NETs and deliver targeted radiation to tumor cells. This approval adds another FDA-approved treatment option for eligible adults with foregut, midgut, and hindgut neuroendocrine tumors. Learn more: globenewswire.com/news-relea… For patients and caregivers, this is an important reminder to talk with your healthcare team about your tumor type, somatostatin receptor status, prior treatments, and whether radioligand therapy may be appropriate for your individual care plan. This information is for educational purposes only and is not medical advice. #NeuroendocrineCancer #NETcancer #gepnets #radioligandtherapy #lutetium177 #curium #PatientEducation #ncfcancer

Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 10

🍂 Take time to pause, reconnect, and embrace transformation. The Neuroendocrine Cancer Foundation invites neuroendocrine cancer patients and caregivers to our Autumn Virtual Health & Wellness Retreat on Saturday, September 26, 2026, from 8:15 AM–12:15 PM Pacific Time. This year’s theme, Transformation, will explore the emotional, mental, social, and behavioral changes that can accompany life with neuroendocrine cancer. Through a supportive, interactive Zoom experience, participants will have an opportunity to step away from the day-to-day and focus on connection, creativity, movement, and mindfulness. The morning will include: 🧘‍♀️ Chair Yoga with Julie Wolinsky 🎨Art Therapy with Angie Madama 🌿Guided Meditation with Ruth Q. Wolever, PhD, NBC-HWC 🗨️ Reflections, Connection & Sharing with Victoria Ramirez, LCSW The retreat is offered at no charge to neuroendocrine cancer patients and caregivers, but space is limited. ✨Learn more and register: ncf.net/retreat We hope you’ll join us for a morning dedicated to wellness, community, and transformation. #NeuroendocrineCancer #NETcancer #cancersupport #cancercaregivers #healthandwellness #mindfulness #arttherapy #yoga #ncfcancer

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Sep 9

Research Opportunity: Carcinoid Syndrome Adults in the United States who are living with carcinoid syndrome may be eligible to participate in a reimbursed, non-promotional market research study conducted by LDA Research Ltd, an independent healthcare market research company. The study aims to better understand patient experiences with carcinoid syndrome, including the patient journey, treatment experiences, symptom management, and the day-to-day impact of living with the condition. Participation may include either: • A 60-minute online interview with a $100 honorarium • A 2-hour online focus group with a $200 honorarium Participation is voluntary, and responses will remain confidential and anonymous. Interested in seeing whether you qualify? Complete the short screening questionnaire here: ldaresearch.questionpro.eu/t… #carcinoidsyndrome #NeuroendocrineCancer #NETcancer #PatientResearch #PatientVoice #CancerResearch #ncfcancer

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Aug 25

Join us for Luncheon With The Experts with J. Randolph Hecht, MD, gastrointestinal medical oncologist at UCLA Health. Dr. Hecht is the Medical Director of the UCLA GI Neuroendocrine Tumor Program and has extensive experience in gastrointestinal oncology, neuroendocrine tumor clinical trials, targeted therapies, immunotherapy, and radiopharmaceutical therapy research. 📅 Thursday, August 27, 2026 ⏰ Noon Eastern / 9 AM Pacific 💻 Watch live on Facebook Live or YouTube Live 📝 No registration needed ❓ Submit your questions live in the Facebook comments or YouTube chat Hosted by Rain Bennett, Luncheon With The Experts is a recurring educational series for patients, caregivers, and the broader neuroendocrine cancer community. Learn more: NCF.net/lwte/aug2026 #NeuroendocrineCancer #NETCancer #PatientEducation #LuncheonWithTheExperts #CancerSupport #NCF

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Aug 22

Join us for When Hormones Interfere With Quality of Life in Neuroendocrine Cancers, a virtual event with Jaydira Del Rivero, MD, endocrinologist and medical oncologist at the National Institutes of Health. Neuroendocrine cancers can sometimes produce hormones that affect daily life. This webinar will explore hormone-related symptoms, how they may impact quality of life, and what patients and caregivers can discuss with their healthcare team. 📅 Thursday, August 27, 2026 ⏰ 1:30–3:00 PM Pacific 💻 Virtual Event 🔗 Register: NCF.net/events/Aug2026 @JaydiDelRivero #NeuroendocrineCancer #NETCancer #PatientEducation #CancerSupport #Hormones #SymptomManagement #NCF

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Aug 15

New podcast episode: NEN Treatments: Focus on Cabozantinib In Episode 54 of the Neuroendocrine Cancer Foundation Podcast, host Lisa Yen speaks with Dr. Namrata “Neena” Vijayvergia, a medical oncologist and clinical trialist, about cabozantinib and what patients and caregivers may want to know. Since its FDA approval on March 26, 2025, cabozantinib has emerged as the newest treatment option for NET patients—adding another valuable tool to the treatment toolbox. It’s become a hot topic in support groups and forums, with many patients wondering what to expect. In this episode, Fox Chase Cancer Center medical oncologist Dr. Namrata (“Neena”) Vijayvergia answers the most frequently asked questions about cabozantinib. She explains how it works, how it differs from other therapies, what patients should know about dosing and side effects, and shares insights on a new clinical trial exploring the next generation of cabozantinib. Listen now: ncf.net/podcast/54 #NeuroendocrineCancer #NETCancer #NeuroendocrineTumor #Cabozantinib #TargetedTherapy #CancerPodcast #PatientEducation #ClinicalTrials #NCF

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Jul 29

Join us for Living With Neuroendocrine Cancer: The Caregiver/Co-Survivor Perspective on Thursday, July 30, 2026. This virtual webinar will feature an open and honest conversation with four individuals who support loved ones living with neuroendocrine cancer. Together, they will share the realities of navigating a parallel journey as caregivers and co-survivors. 🗓️ Thursday, July 30, 2026 ⏲️ 12–1 PM Pacific 👉 For caregivers, patients, families, and the broader neuroendocrine cancer community Register here: ncf.net/events/july2026 #NeuroendocrineCancer #NETcancer #caregiversupport #cancercaregivers #cosurvivor #PatientEducation #ncfcancer #neuroendocrinetumors

Post attachment
Neuroendocrine Cancer Foundation avatar
Neuroendocrine Cancer Foundation@NCFCancer·Jul 24

We are honoring the life and legacy of Tom Bajoras — beloved husband of Lisa Yen, NCF’s Director of Programs & Outreach, and a cherished member of the neuroendocrine cancer community. Tom lived with neuroendocrine cancer for more than eleven years and shared his music, creativity, kindness, and service with so many. From performing original piano pieces at the 2023 NET Cancer Day Symposium to composing and editing music for the NCF podcast, Tom’s contributions touched our community in ways both seen and unseen. In 2023, Tom received the Giovanna Joyce Imbesi Above & Beyond Award, recognizing his dedication to the NET community and the meaningful connection he created through music. We are grateful for the beauty Tom shared, the journey he offered, and the love he brought into this community. Read our tribute: ncf.net/post/honoring-tom-ba… #NeuroendocrineCancer #NETcancer #ncfcancer #cancercommunity

Post attachment